Ohyashiki K, Ohyashiki J H, Otaki K, Yoshida M A, Raza A, Preisler H D, Sandberg A A
Cancer Genet Cytogenet. 1987 Feb;24(2):281-94. doi: 10.1016/0165-4608(87)90110-5.
Four cases of chronic myelogenous leukemia (CML) with complex Philadelphia (Ph) translocations are described. The first case was that of a 50-year-old woman in the chronic phase of CML. Her leukemic cells showed a complex Ph translocation involving chromosomes #9, #11, and #22 [i.e., t(9;9;22;11)(11qter----11q11::9q11----9q34:: 9p11----9pter;22qter----22q11::9q34?;11 pter----11q11::22q11----22qter)]. In addition to the complex Ph translocation, the leukemic cells contained del(10)(p13). The second case was that of a 21-year-old man whose leukemic cells contained a translocation involving chromosomes #5, #9, and #22 [i.e., t(5;22;9)(q31;q11;q34)], resulting in a "masked" Ph chromosome. The third case was that of a 37-year-old man whose leukemic cells had a complex Ph translocation involving chromosomes #8, #9, and #22 [i.e., t(8;9;22)(q13;q34;q11)]. The fourth patient was a 41-year-old woman diagnosed as having CML in myeloid blastic phase, at which time the first specimen was examined by us. This blood sample showed a karyotype of 45,XX, -9, -17, -22, +mar1, +mar2,9q+. No Ph chromosome was present. A standard Ph translocation was detected in the cells obtained from the spleen, when the patient underwent splenectomy for treatment of the blastic crisis. Subsequent specimens obtained from the blood and bone marrow showed that the leukemic cells contained three clones: 45,XX, -9, -17, -22, +mar1, +mar2,9q+/46,XX, -17, +mar1,t(9;22)(q34;q11)/46,XX,t(9;22)(q34;q11). Cells with the "masked" Ph chromosome were thought to have been derived from the clone with the standard Ph translocation. We postulate that some variant Ph translocations, including those with a "masked" Ph chromosome, may be generated by a stepwise process following the genesis of a standard Ph translocation.
本文描述了4例伴有复杂费城(Ph)染色体易位的慢性粒细胞白血病(CML)。第一例是一名处于CML慢性期的50岁女性。她的白血病细胞显示出涉及9号、11号和22号染色体的复杂Ph染色体易位[即t(9;9;22;11)(11qter----11q11::9q11----9q34:: 9p11----9pter;22qter----22q11::9q34?;11 pter----11q11::22q11----22qter)]。除了复杂的Ph染色体易位外,白血病细胞还含有del(10)(p13)。第二例是一名21岁男性,其白血病细胞含有涉及5号、9号和22号染色体的易位[即t(5;22;9)(q31;q11;q34)],产生了一条“隐匿”的Ph染色体。第三例是一名37岁男性,其白血病细胞具有涉及8号、9号和22号染色体的复杂Ph染色体易位[即t(8;9;22)(q13;q34;q11)]。第四例患者是一名41岁女性,被诊断为处于髓系母细胞期的CML,此时我们检查了其第一份标本。该血样显示核型为45,XX, -9, -17, -22, +mar1, +mar2,9q+。不存在Ph染色体。当该患者因母细胞危象接受脾切除术时,在从脾脏获取的细胞中检测到了标准的Ph染色体易位。随后从血液和骨髓获取的标本显示,白血病细胞包含三个克隆:45,XX, -9, -17, -22, +mar1, +mar2,9q+/46,XX, -17, +mar1,t(9;22)(q34;q11)/46,XX,t(9;22)(q34;q11)。具有“隐匿”Ph染色体的细胞被认为源自具有标准Ph染色体易位的克隆。我们推测,一些变异的Ph染色体易位,包括那些具有“隐匿”Ph染色体的易位,可能是在标准Ph染色体易位发生后通过一个逐步过程产生的。